PBMs extract enormous rebates, prior authorization adds friction, and adherence suffers
New analysis of GLP-1 drugs suggests people who stopped using medications regained 60% of weight lost A new study, recently shared on Good Morning America , on life after weight loss drugs examined 48 studies that analyzed and predicted the outcomes of people who either had diabetes or were overweight or obese and took popular GLP-1 medications
Therefore, effective neuroprotective therapies are continuously being pursued
The American College of Cardiology/American Heart Association/The Obesity Society guidelines emphasize individualized treatment plans incorporating lifestyle modification, behavioral therapy, pharmacotherapy when appropriate, and metabolic/bariatric surgery for eligible patients
our model assumes a 25% annual attrition rate, and that lapsed patients regain about two-thirds of the weight lost. Household impacts While survey data focuses on people taking obesity medicines, we could see a greater change to food consumption if the behavioral changes affect people in AOM patients households or social circles, speculates Morgan Stanley
Funding Statement This research received no external funding